Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-483.86	-28.51	-4.88
Graham Fair Price	-56.76	47684.87	110278.07
PEG	1535.03	0.11	< 0.005
Price/Book	2.58	0.61	0.60
Price/Cash Flow	-94.13	-6.66	113.31
Prices/Earnings	-421.36	-9.00	-1.73
Price/Sales	0.35	3.40	3.39
Price/FCF	-94.13	-6.66	113.31
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-96.10	< 0.005	-0.03
Operating Margin	78.27	-0.12	-0.57
ROA	79.17	-0.02	-0.08
ROE	-0.09	-0.02	80.32
ROIC	-0.09	-0.02	80.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.27	-0.36	26.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.12	0.78	-74.94
EPS QOQ	-2.53	0.81	-68.11
FCF QOQ	1.41	-18.17	1191.22
Revenue QOQ	0.08	< 0.005	-93.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	67.59	69.63	3.02
Days Sales Outstanding (DSO)	150.09	156.08	3.99
Inventory Turnover	1.33	1.29	-2.93
Debt/Capitalization	< 0.005	< 0.005	-25.35
Quick Ratio	3.01	4.53	50.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	79182.40	77187.77	-2.52
Cash	11937.69	5144.93	-56.90
Capex	304.50	-17.16	-94.37
Free Cash Flow	416.12	-7083.04	1602.16
Revenue	13909.52	13860.84	-0.35
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	3.99	6.33	58.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.19	1.68	41.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating